When a company that takes care of your medical records is at the center of not one but two lawsuits, you should pay attention. LabCorp, which used to be called Laboratory Corporation of America Holdings, has been quietly dealing with some serious legal issues for the past few years. And the effects are more personal than most people think for millions of regular Americans.
In the first thread, there is a data breach. A big security breach at the American Medical Collection Agency, a billing company that did work for LabCorp and other big healthcare companies, let sensitive patient data slip. Things like names, addresses, dates of birth, and Social Security numbers that can’t be hidden once they’re out in the open. Since then, the class action lawsuit, which was filed in the District of New Jersey with the case number 19-md-2904, has been making its way through the courts. A settlement has now been suggested, and important due dates are coming up for class members.
If you got a notice about the American Medical Collection Agency LabCorp settlement, your options are pretty clear, but it’s easy to ignore them. You can object, file a claim, or leave the group. If you don’t do anything, you have to stay in class, get no pay, and possibly never be able to sue LabCorp again for anything related to the AMCA breach. It’s the kind of small print that most people will probably skip over. The Last Fairness Hearing will take place at the Martin Luther King Federal Courthouse in Newark, New Jersey, on August 20, 2026. For objections to be valid, they had to be postmarked by July 27, 2026.
Watching these cases go through the system makes me think that there is a huge disconnect between the legal system and the public. A postcard from a classmate usually tells people they’re in the same group months after the event. Even though the law is still at stake, the emotional urgency has worn off by that point.
From the point of view of public trust, the second thread might be more concerning. On a different note, LabCorp agreed to pay $14.5 million to settle claims that it sent false claims to Medicare for urine drug tests it sold under the name “ToxAssure Comprehensive.” The government thought that LabCorp set up its testing panel so that it could make the most money, not because it was medically necessary. LabCorp regularly billed Medicare for both a high-tier presumptive test code and the highest-tier definitive test code from January 2018 to November 2023, according to facts admitted in the settlement. This meant that they charged the highest possible rate for the same patient visit and urine sample.
It is very hard to defend the billing arrangement because LabCorp did direct definitive tests on some substances without first doing the kind of tests that would normally tell them if a more detailed test was even needed. To put it simply, they skipped the pricey test and went right to it without first making sure it was needed. In the end, Medicare and taxpayers paid for it both ways.
As part of the settlement, LabCorp admitted that these things were true. Even though the dollar amount seems vague when seen in its entirety, that admission is important. 14.5 million dollars is a lot of money for most people, but it’s not a big deal for a company that makes billions of dollars a year. No one outside the company can really say right now if the settlement changes how people act inside the company or just makes the cost of occasional scrutiny clear.
Still not clear how many patients got tests that weren’t really needed and how many got the full panel of tests because it was clinically appropriate for them. The edges of medicine are rarely clean. But the way ToxAssure Comprehensive is set up—preselected, bundled, and billed at maximum rates—raises concerns that go beyond the choices made by each patient about their care.
What these two cases have in common is that they both involve billing and data-handling systems that worked mostly behind the scenes for years before anyone outside the company started to ask tough questions. It’s not just LabCorp that does that. In general, that’s how healthcare administration works. But it’s a good reminder that the paperwork that comes out of a normal urine or blood test is more important legally and financially than most patients realize.
